Proteomics Market Outlook:
Proteomics Market size was valued at USD 35.46 Billion in 2025 and is likely to cross USD 125.8 Billion by 2035, registering more than 13.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of proteomics is assessed at USD 39.77 Billion.
The expansion of the market is being driven by the rise in chronic diseases such as cancer, diabetes, CVDs, respiratory disorders, CKD, and others on a global scale. It is also feasible to locate anticancer drugs and modify cancer treatment with oncoprotein. Proteomics is becoming more and more necessary due to the utilization of oncoproteins in the brain, colon, breast, rectum, prostate, and other tissues for cancer treatment. Proteomics can be used to find new therapeutic options as well as diagnose cancer. Almost one in six deaths in 2020, or over 10 million deaths, were related to cancer, according to the WHO.
In addition to these, the growing demand for personalized medicines and better diagnostics to treat targeted diseases, as well as the disproportionate incidence of target diseases, is providing a major driving force behind the increased demand for proteomics. Prophylactics are becoming dominant in the medical sector. The high accuracy and susceptibility of mass spectrometric study of proteomes are well matched for the integration of proteomics into precision medicine. The future of personalized medicine is based on using proteomics in the clinic, according to NCBI. The efficient application of personal proteomics to diagnose and treat conditions depends upon the appropriate translation of scientific findings into medical practice. Precision medicine is aimed at ensuring that each individual patient gets the best possible outcome by being more precisely and effectively matched to the most appropriate treatment regimen. Early diagnosis of the disease status and severity, as well as improved patient outcomes through a rapid proteomic examination of easily accessible tissue samples enables medical staff to respond more quickly in case of emergency. Due to the advantages of personalized proteomics, there has been a rapid growth in this proteomics market.
